跳至主要内容
临床试验/NCT05480176
NCT05480176招募中不适用

The National Chronic Obstructive Pulmonary Disease Screening Program in China

China-Japan Friendship Hospital1 个研究点 分布在 1 个国家目标入组 800,000 人开始时间: 2021年10月9日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
800,000
试验地点
1
主要终点
Lung function

研究概览

简要总结

The national COPD screening program is in a cross-sectional manner at the baseline, planning to recruit a total of 800,000 participants from 160 districts or counties (5,000 for each site on average) from 31 provinces, autonomous regions or municipalities directly under the central government of China. The filtered COPD high-risk population and confirmed COPD patients will be managed and followed up according to the standardized clinical guidelines. The major aims of the program are to estimate the prevalences of COPD high-risk population and under- or miss- diagnosed COPD patients, and to manage the development and outcomes of the disease.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
35 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • adults aged between 35 and 75 years;
  • residents living in the survey area with more than 6 months in the past year.

排除标准

  • experienced myocardial infarction, stroke or shock in the past 3 months;
  • experienced severe cardiac insufficiency, severe arrhythmia or unstable angina pectoris in the past 4 weeks;
  • experienced massive hemoptysis in the past 4 weeks;
  • received chest, abdominal or ophthalmic surgery in the past 3 months;
  • have mental disorders (e.g. auditory hallucinations, visual hallucinations, taking antipsychotics, seizures requiring medication, etc.);
  • have cognitive impairment (e.g. dementia, comprehension impairment, etc.);
  • have uncontrolled hypertension (i.e. systolic blood pressure > 200 mmHg, diastolic blood pressure > 100 mmHg);
  • present with heart rate >120 beats/min;
  • have aortic aneurysm;
  • have severe hyperthyroidism;
  • are pregnant or lactating women;
  • experienced respiratory infectious diseases (e.g. tuberculosis, influenza, etc.) in the past month.

结局指标

主要结局

Lung function

时间窗: 2 years

The changes of lung function (e.g. FEV1, FVC, FEV1/FVC, etc.) (P.S.: it is hard to assume that the lung function would be improved or decling, especially for the pre- or early-COPD population)

次要结局

  • Respiratory symptoms(2 years)
  • Exacerbations(2 years)

研究者

发起方
China-Japan Friendship Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ting YANG

Prof.

China-Japan Friendship Hospital

研究点 (1)

Loading locations...

相似试验

The China National COPD Screening Program | 临床试验